CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
-4.24%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$281M
AUM Growth
+$281M
(+9.7%)
Cap. Flow
+$51.3M
Cap. Flow
% of AUM
18.23%
Top 10 Holdings %
Top 10 Hldgs %
95.46%
Holding
22
New
3
Increased
8
Reduced
7
Closed
1
Top Buys
| 1 |
INZY
Inozyme Pharma
INZY
|
$26.5M |
| 2 |
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
|
$20.7M |
| 3 |
American Well
AMWL
|
$7.36M |
| 4 |
Pliant Therapeutics
PLRX
|
$1.05M |
| 5 |
Corvus Pharmaceuticals
CRVS
|
$879K |
Top Sells
| 1 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$2.94M |
| 2 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$1.59M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$886K |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$510K |
| 5 |
Kezar Life Sciences
KZR
|
$457K |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Communication Services | 0.18% |
